InSite Vision, Inc.

Sun Pharmaceutical Industries Ltd. became the third company to gain US FDA approval of a drug for dry eye disease Aug. 16, as Cequa (cyclosporine ophthalmic solution 0.09%) was approved to increase

A year ago, Sun Pharmaceutical Industries Ltd. paid $48m for California-based InSite Vision Inc. , which focuses on developing specialty ophthalmic products. The purchase was a key building blo

A recent discussion in Mumbai on trends in the pharmaceutical and healthcare sector especially from the mergers and acquisitions (M&A) and funding perspective highlighted the appetite of large Indian

Pfizer's former global marketing director Aimee De Blasis Amann has agreed not to disclose or use Pfizer Inc. 's trade secrets and to permit an independent computer forensic specialist to inspect h